个性化文献订阅>期刊> Bioorganic & Medicinal Chemistry Letters
 

II. Novel HCV NS5B polymerase inhibitors: Discovery of indole C2 acyl sulfonamides

  作者 Anilkumar, GN; Selyutin, O; Rosenblum, SB; Zeng, QB; Jiang, YH; Chan, TY; Pu, HY; Wang, L; Bennett, F; Chen, KX; Lesburg, CA; Duca, J; Gavalas, S; Huang, YH; Pinto, P; Sannigrahi, M; Velazquez, F; Venkatraman, S; Vibulbhan, B; Agrawal, S; Ferrari, E; Jiang, CK; Huang, HC; Shih, NY; Njoroge, FG; Kozlowski, JA  
  选自 期刊  Bioorganic & Medicinal Chemistry Letters;  卷期  2012年22-1;  页码  713-717  
  关联知识点  
 

[摘要]Development of SAR at the C2 position of indole lead 1, a palm site inhibitor of HCV NS5B polymerase (NS5B IC(50) = 0.053 mu M, replicon EC(50) = 4.8 mu M), is described. Initial screening identified an acyl sulfonamide moiety as an isostere for the C2 carboxylic acid group. Further SAR investigation resulted in identification of acyl sufonamide analog 7q (NS5B IC(50) = 0.039 mu M, replicon EC(50) = 0.011 mu M) with >100-fold improved replicon activity. (C) 2011 Elsevier Ltd. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内